Perspectives in chronic lymphocytic leukemia biology and management

被引：4

作者：

Dighiero, G ^{[1
]}

机构：

[1] Inst Pasteur, Unite Immuno Hematol & Immunopathol, F-75724 Paris 15, France

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2004年 / 18卷 / 04期

关键词：

D O I：

10.1016/j.hoc.2004.04.002

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Considerable progress has been achieved in the comprehension of the pathogenesis, prognosis, assessment, and treatment of chronic lymphocytic leukemia. However, this progress also has introduced new enigmas in the fields of biology, prognosis, and treatment. This article discusses some unanswered questions in these different topics.

引用

页码：927 / +

页数：18

共 108 条

[1] Cytokine expression in B-CLL in relation to disease progression and in vitro activation [J].

Aguilar-Santelises, M ;

Gigliotti, D ;

Osorio, LM ;

De Santiago, A ;

Mellstedt, H ;

Jondal, M .

MEDICAL ONCOLOGY, 1999, 16 (04) :289-295

[2]

ALBESIANO E, 2003, BLOOD, V102, P375

[3]

[Anonymous], 1990, Blood, V75, P1422

[4]

[Anonymous], 1999, J Natl Cancer Inst, V91, P861

[5]

BINET JH, 1986, LANCET, V1, P1346

[6]

BINET JL, 1990, BRIT J HAEMATOL, V76, P45

[7]

BINET JL, 1981, CANCER-AM CANCER SOC, V48, P198, DOI 10.1002/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO

[8]

2-V

[9]

BINET JL, 1987, SEMIN HEMATOL, V24, P275

[10]

BORCHE L, 1990, BLOOD, V76, P562

← 1 2 3 4 5 6 7 8 9 10 →